| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.83 | 0.0008 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.3 | 3e-08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.28 | 5e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.27 | 4e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.26 | 1e-06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.003 |